277 results on '"Kawasaki, Yoshihide"'
Search Results
2. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study
3. Real-world outcomes of patients with renal cell carcinoma, surgically treated at regional hospitals, based on a prospective long-term survey of the pre-robotic era
4. PD51-07 REGULATION OF GLUTAMINE METABOLISM RESENSITIZES TKI-RESISTANT RENAL CANCER CELLS TO TKIS
5. A case of testicular tumor and respiratory failure caused by choriocarcinoma syndrome managed through modified chemotherapy and extracorporeal membrane oxygenation
6. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
7. Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
8. Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
9. Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism
10. Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell Carcinoma.
11. Contemplation of the Effect of Nivolumab Plus Cabosantinib Therapy on Cerebral Hemorrhage in Patients with Brain Metastasis of Renal Cell Carcinoma: A Case Report
12. Intravenously Engrafted Human Muse Cells Rescue Erectile Function after Rat Cavernous Nerve Injury
13. Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury.
14. Glutamine metabolism and VEGF analysis to elucidate and overcome the mechanism of tyrosine kinase inhibitor resistance in renal cell carcinoma.
15. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
16. Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma
17. A case of testicular cancer with retroperitoneal lymph node metastasis of teratoma with somatic‐type malignancy 18 years after initial treatment
18. The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.
19. Laparoscopic Adrenalectomy
20. Impact of Tissue Sealing Sheet on Erectile Dysfunction in a Rat Model of Nerve-Sparing Radical Prostatectomy
21. Evaluating estimated glomerular filtration rates of creatinine and cystatin C for male patients with chronic spinal cord injury
22. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
23. Impact of Adrenalectomy on Diastolic Cardiac Dysfunction in Patients with Primary Aldosteronism
24. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status
25. Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study
26. Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report
27. Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study
28. Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma
29. 水腎症を解除しても腎機能廃絶を回避できなかったIgG4関連尿細管間質性腎炎の1例
30. Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study.
31. Laparoscopic Adrenalectomy Is Beneficial for the Health-Related Quality of Life of Older Patients with Primary Aldosteronism.
32. Severe Inflammatory Idiopathic Multicentric Castleman's Disease Coexisting with Advanced Renal Cancer: A Case Report
33. External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study
34. Predictive model for recurrence of renal cell carcinoma by comparing pre‐ and postoperative urinary metabolite concentrations
35. Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
36. IMPACT OF TISSUE SEALING SHEET ON ERECTILE DYSFUNCTION IN A RAT MODEL OF NERVE-SPARING RADICAL PROSTATECTOMY: MP86-07
37. PROSPECTIVE EVALUATION OF THE IMPACT OF TREATMENT FOR TESTICULAR CANCER ON SEXUAL FUNCTION: MP47-20
38. MEDIUM-TERM OUTCOMES AFTER LAPAROSCOPIC ADRENALECTOMY FOR PRIMARY ALDOSTERONISM: MP12-06
39. DIFFERENCES BETWEEN EXTRA-ADRENAL PARAGANGLIOMAS AND PHEOCHROMOCYTOMAS IN MALIGNANT POTENTIAL: MP12-12
40. Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma
41. Renal Injuries in Primary Aldosteronism (PA) ~Quantitative Histopathological Analysis of 19 PA patients~
42. MP14-17 VALIDATION OF REMARCC MODEL FOR SELECTION OF CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH mRCC
43. Clinical predictors of severe late urinary toxicity after curative intensity-modulated radiation therapy for localized prostate cancer
44. Laparoscopic Adrenalectomy Is Beneficial for the Health-Related Quality of Life of Older Patients with Primary Aldosteronism
45. Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism
46. Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
47. PD3-02 IN PRIMARY ALDOSTERONISM WITH BILATERAL ADRENAL ADNOMAS, LAPAROSCOPIC BILATERAL ADRENAL SURGERY COULD BE AN OPTIONAL TREATMENT UNDER SELECTIVE ADRENAL VENOUS SAMPLING
48. Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute
49. Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma
50. The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.